Cirrus Pharmaceuticals, Inc. is a contract product development company assisting biotechnology and pharmaceutical companies with dosage form development projects. Cirrus works with start-up, mid-size and multinational companies to provide a broad array of R&D services including physical and chemical characterization, formulation development, stability testing, container/closure selection, process development, as well as scale-up and technical transfer to manufacturing. Cirrus is proud to offer the world-class services of our scientific talent with expertise in the areas of inhaled, oral, topical, transdermal and parenteral product development. Cirrus also provides submission-ready regulatory documentation and assistance with government agency filings. The company is headquartered in Research Triangle Park, North Carolina. Cirrus Pharmaceuticals, Inc. is registered with the United States Food and Drug Administration (FDA) and is a cGMP compliant facility.
Cirrus was founded by Dr. Anthony (Tony) Hickey and Dr. Jean-Marc Bovet. Since its creation, Cirrus has significantly expanded its capabilities to address many aspects of drug development process. The growth of the company is due largely to its focus on providing timely and efficient research and product development support to the global pharmaceutical and biotech industries. The commitment of Cirrus to exceptional service is reflected in our outstanding rate of return business. It is the combination of scientific competency and the timely delivery of quality services that keeps our clients coming back time and time again. Cirrus’ strategic product development staff is comprised of highly talented formulations, analytical and regulatory experts with a broad diversity in professional, educational and cultural backgrounds. Cirrus’ experienced professionals work side by side with our clients to expedite all of their research goals and project timelines.
With Cirrus, expect expertise!
Last Updated: 03-26-2008